Advertisement
Home »

CircRTN4 aggravates mesangial cell dysfunction by activating the miR-513a-5p/FN axis in lupus nephritis.

Feb 13, 2023

REFERENCES & ADDITIONAL READING

PubMed

ABOUT THE CONTRIBUTORS

  • Xinyan Miao

    Department of Pathology; Center of Metabolic Diseases and Cancer Research, Institute of Medical and Health Science, Hebei Medical University; Key Laboratory of Kidney Diseases of Hebei Province, 050017, Shijiazhuang, China.

    Yuexin Tian

    Department of Pathology; Center of Metabolic Diseases and Cancer Research, Institute of Medical and Health Science, Hebei Medical University; Key Laboratory of Kidney Diseases of Hebei Province, 050017, Shijiazhuang, China.

    Lunbi Wu

    Department of Pathology; Center of Metabolic Diseases and Cancer Research, Institute of Medical and Health Science, Hebei Medical University; Key Laboratory of Kidney Diseases of Hebei Province, 050017, Shijiazhuang, China.

    Hang Zhao

    Department of Pathology; Center of Metabolic Diseases and Cancer Research, Institute of Medical and Health Science, Hebei Medical University; Key Laboratory of Kidney Diseases of Hebei Province, 050017, Shijiazhuang, China.

    Jinxi Liu

    Department of Pathology; Center of Metabolic Diseases and Cancer Research, Institute of Medical and Health Science, Hebei Medical University; Key Laboratory of Kidney Diseases of Hebei Province, 050017, Shijiazhuang, China.

    Fan Gao

    Department of Pathology; Center of Metabolic Diseases and Cancer Research, Institute of Medical and Health Science, Hebei Medical University; Key Laboratory of Kidney Diseases of Hebei Province, 050017, Shijiazhuang, China.

    Wei Zhang

    Department of Pathology; Center of Metabolic Diseases and Cancer Research, Institute of Medical and Health Science, Hebei Medical University; Key Laboratory of Kidney Diseases of Hebei Province, 050017, Shijiazhuang, China.

    Qingjuan Liu

    Department of Pathology; Center of Metabolic Diseases and Cancer Research, Institute of Medical and Health Science, Hebei Medical University; Key Laboratory of Kidney Diseases of Hebei Province, 050017, Shijiazhuang, China.

    Huifang Guo

    Department of Rheumatology, The Second Hospital of Hebei Medical University, 050000, Shijiazhuang, China.

    Lin Yang

    Department of Nephrology, The Second Hospital of Hebei Medical University, 050000, Shijiazhuang, China.

    Ran Yang

    Department of Pathology, Hebei Province Hospital of Chinese Medicine, 050013, Shijiazhuang, China.

    Xiaojuan Feng

    Department of Pathology; Center of Metabolic Diseases and Cancer Research, Institute of Medical and Health Science, Hebei Medical University; Key Laboratory of Kidney Diseases of Hebei Province, 050017, Shijiazhuang, China. Electronic address: fengxiaojuan1985@163.com.

    Shuxia Liu

    Department of Pathology; Center of Metabolic Diseases and Cancer Research, Institute of Medical and Health Science, Hebei Medical University; Key Laboratory of Kidney Diseases of Hebei Province, 050017, Shijiazhuang, China. Electronic address: shuxialiu@hebmu.edu.cn.

MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.


EXPLORE MORE

Advertisement
Advertisement
ad
ad
MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.

SUBSCRIBE NOW

View all newsletters

RELEVANT ARTICLES FOR YOU

Advertisement